Day: June 24, 2020

TORONTO, June 24, 2020 (GLOBE NEWSWIRE) — Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that the Company has completed shipping the second 10,000 purchase order of COVID-19 test kits (the “PO”) to a Canadian based mining company with operations worldwide.The total gross sales amount is approximately $500,000 CDN, excluding shipping fees. Datametrex anticipates that it has little or no upfront costs associated with the sale of these test kits.  All of the items are shipped from manufacturers to the purchaser’s mine operating sites in Ontario and Quebec.Under the terms of the PO, Datametrex provides them with an initial 10,000 units of the COVID-19 qPCR Detection Kits manufactured by 1drop Inc. (“1drop”), 10,000 Universal Transport...

FRISCO, Texas, June 24, 2020 (GLOBE NEWSWIRE) — Ecoark Holdings, Inc. (“Ecoark”) (OTC: ZEST), announced that its wholly owned subsidiary, White River SPV 2 LLC, appeared virtually before the United States Bankruptcy Court for the Southern District of Texas, Houston Division on June 18, 2020 and completed the acquisition of certain assets located in Mississippi and Louisiana from SN TMS, LLC, a subsidiary of Sanchez Energy Corporation (“Sanchez Energy”), in conjunction with Chapter 11 Case No. 19-34508 (MI). The all-cash transaction, paid from existing cash on hand, includes 6 wellbores and additional leasehold acreage including a participation option for deep drilling rights on various acreage with proved reserves. This transaction follows Ecoark’s announcement made on June 11, 2020 regarding the acquisition of 262 total...

NEWTON, Mass., June 24, 2020 (GLOBE NEWSWIRE) — Karyopharm Therapeutics Inc. (Nasdaq:KPTI), an innovation-driven pharmaceutical company, today announced that the results of the Phase 2b SADAL (Selinexor Against Diffuse Aggressive Lymphoma) study evaluating XPOVIO in patients with relapsed or refractory diffuse large B-cell lymphoma (RR DLBCL) were published online in The Lancet Haematology. The SADAL study evaluated selinexor, the Company’s first-in-class, oral Selective Inhibitor of Nuclear Export (SINE) compound for the treatment of adult patients with RR DLBCL, not otherwise specified, who have received at least two prior therapies.  “The clinical outcomes for patients with heavily pretreated relapsed or refractory DLBCL are typically very poor, and hence results from the multinational Phase 2b SADAL study are noteworthy,” said...

VANCOUVER, British Columbia, June 24, 2020 (GLOBE NEWSWIRE) — Calibre Mining Corp. (“Calibre” or the “Company”) (TSX: CXB; OTCQX: CXBMF) is pleased to provide its revised 2020 production and cost guidance following the temporary suspension of operations, as announced on March 25, 2020.After a 10-week suspension of operations, Calibre now expects 2020 gold production of between 110,000 and 125,000 ounces at Total Cash Costs1 of between $880 and $920 and All-In Sustaining Costs2 of between $1,070 and $1,100 an ounce, respectively (all numbers expressed in United States dollars).The Company has resumed exploration drilling with an expanded 60,000 metre program, increased from 47,000 metres. In addition, an unbudgeted 20,000 metre infill drilling program is underway (at sustaining capital costs of approximately $2.5 million) targeting...

– Band n77 RF Filter Solution Qualified and Designed into 5G Small Cell Product –– New XBAW Filter Expected to Enter Production in Current Calendar Year –Charlotte, N.C., June 24, 2020 (GLOBE NEWSWIRE) — Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, announced today that it has been awarded a second design win for band n77 XBAW™ filters for 5G network infrastructure equipment from its tier-1 customer. The Company expects to enter commercial production in the second half of calendar 2020.Akoustis’ recently announced wide bandwidth n77 XBAW™ filter has now been qualified in the initial build of 5G small cell base station systems. Akoustis completed initial sample shipments...

NEW YORK, June 24, 2020 (GLOBE NEWSWIRE) — iBio, Inc. (NYSE AMERICAN:IBIO) (“iBio” or the “Company”), a biologics contract manufacturing organization and biotechnology company, today announced that IBM Watson Health has selected iBio to receive 18 months of use of the IBM Clinical Development (ICD) solution, free-of-charge.IBM Watson Health recently began offering its ICD solution to eligible trial sponsor organizations as part of its efforts to help support the medical community to address the COVID-19 pandemic. IBM Watson Health has received interest in the offering from numerous hospitals, sponsors, contract research organizations and academic institutions, and is currently enabling 15 COVID-19 disease trials.“We are deeply appreciative of IBM’s vote-of-confidence, which recognizes the potential of iBio’s COVID-19 vaccine development...

Date: Thursday, August 6, 2020Time: 12:00 p.m. (Eastern Time)BROOKFIELD NEWS, June 24, 2020 (GLOBE NEWSWIRE) — You are invited to participate in Brookfield Business Partners’ 2020 Second Quarter Conference Call & Webcast on Thursday, August 6, 2020 at 12:00 p.m. (Eastern Time) to discuss with members of senior management our results and current business initiatives.Results will be released on Thursday, August 6, 2020 prior to 8:00 a.m. (Eastern Time) and will be available following the release on our website at https://bbu.brookfield.com.To participate in the Conference Call please dial +1 (866) 688-9431 toll-free in the U.S and Canada or for overseas calls please dial +1 (409) 216-0818 (Conference ID 3838218) at approximately 11:50 a.m. (Eastern Time). Live audio of the Conference Call will be available via webcast on our...

Roblon downgrades guidance for 2019/20Interim report – H1 2019/20 (the period 1 November 2019 – 30 April 2020)

Roblon nedjusterer forventningerne til regnskabsåret 2019/20Delårsrapport for 1. halvår 2019/20 (perioden 1. november 2019 – 30. april 2020)